What is the ROCE (Return on Capital Employed) of Aerie Pharmaceuticals this year?
The ROCE of Aerie Pharmaceuticals is 2.67 undefined this year.
Aerie Pharmaceuticals ROCE 2024
Aerie Pharmaceuticals ROCE
2.67
Aerie Pharmaceuticals Dividend yield
Ticker
AERI
ISIN
US00771V1089
WKN
A1W7RL
In 2024, Aerie Pharmaceuticals's return on capital employed (ROCE) was 2.67, a 0% increase from the 0 ROCE in the previous year.
Aerie Pharmaceuticals Aktienanalyse
What does Aerie Pharmaceuticals do?
Aerie Pharmaceuticals Inc is a US-based company specializing in the development of drugs for the treatment of eye diseases. The company was founded in 2005 by David Epstein and is headquartered in Durham, North Carolina. Aerie Pharmaceuticals aims to use innovative thinking and the latest technologies to improve the treatment of eye diseases and enhance the lives of people worldwide. They have developed several drugs that are already available on the market. Their main focus is on researching and developing eye medications, particularly those that can reduce intraocular pressure in patients with glaucoma. Their key drugs are Rhopressa and Rocklatan. In addition, they have plans to develop and market more products for the treatment of eye diseases. They collaborate with various partners including pharmaceutical distributors and pharmacies to bring their medications to the market globally. Overall, Aerie Pharmaceuticals is a leading provider of ophthalmic drugs and is dedicated to revolutionizing the treatment of eye diseases. Aerie Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Aerie Pharmaceuticals's Return on Capital Employed (ROCE)
Aerie Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Aerie Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Aerie Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Aerie Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Aerie Pharmaceuticals Stock
How has the ROCE (Return on Capital Employed) of Aerie Pharmaceuticals developed compared to the previous year?
The ROCE of Aerie Pharmaceuticals has increased by 0% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Aerie Pharmaceuticals?
A high Return on Capital Employed (ROCE) indicates that Aerie Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Aerie Pharmaceuticals?
A low ROCE (Return on Capital Employed) can indicate that Aerie Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Aerie Pharmaceuticals impact the company?
An increase in the ROCE of Aerie Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Aerie Pharmaceuticals affect the company?
A decrease in ROCE of Aerie Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Aerie Pharmaceuticals?
Some factors that can affect Aerie Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Aerie Pharmaceuticals so important for investors?
The ROCE of Aerie Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Aerie Pharmaceuticals take to improve the ROCE?
To improve the ROCE, Aerie Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Aerie Pharmaceuticals pay?
Over the past 12 months, Aerie Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aerie Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Aerie Pharmaceuticals?
The current dividend yield of Aerie Pharmaceuticals is .
When does Aerie Pharmaceuticals pay dividends?
Aerie Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aerie Pharmaceuticals?
Aerie Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Aerie Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aerie Pharmaceuticals located?
Aerie Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aerie Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aerie Pharmaceuticals from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.
When did Aerie Pharmaceuticals pay the last dividend?
The last dividend was paid out on 6/6/2024.
What was the dividend of Aerie Pharmaceuticals in the year 2023?
In the year 2023, Aerie Pharmaceuticals distributed 0 USD as dividends.
In which currency does Aerie Pharmaceuticals pay out the dividend?
The dividends of Aerie Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aerie Pharmaceuticals
Our stock analysis for Aerie Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aerie Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Aerie Pharmaceuticals Revenue
- Aerie Pharmaceuticals Net Income
- Aerie Pharmaceuticals P/E
- Aerie Pharmaceuticals P/S
- Aerie Pharmaceuticals EBIT
- Aerie Pharmaceuticals Dividend
- Aerie Pharmaceuticals Stocks
- Aerie Pharmaceuticals Market capitalization
- Aerie Pharmaceuticals Debt
- Aerie Pharmaceuticals Liabilities
- Aerie Pharmaceuticals Equity
- Aerie Pharmaceuticals AAQS
- Aerie Pharmaceuticals Employees
- Aerie Pharmaceuticals ROE
- Aerie Pharmaceuticals ROA
- Aerie Pharmaceuticals ROCE
